Corrigendum to "A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site" [Eur J Cancer (2026) 239 116709].
Saved in:
| Title: | Corrigendum to "A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site" [Eur J Cancer (2026) 239 116709]. |
|---|---|
| Authors: | Monzon, Jose G.1 (AUTHOR) jose.monzon@albertahealthservices.ca, Karachiwala, Hatim1 (AUTHOR), Walker, John2 (AUTHOR), Goel, Rakesh3 (AUTHOR), Wheatley-Price, Paul3 (AUTHOR), Asmis, Timothy R.3 (AUTHOR), Navani, Vishal1 (AUTHOR), Tang, Patricia A.1 (AUTHOR), Vickers, Michael M.3 (AUTHOR) |
| Source: | European Journal of Cancer. Jun2026, Vol. 240, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
